CX-546 is an ampakine drug developed by Cortex Pharmaceuticals.
CX-546 is an ampakine drug developed by Cortex Pharmaceuticals.
It has been proposed as a treatment for schizophrenia. CX-546 was the second drug of note to come out of the Cortex research program, after CX-516, but while it was an improvement over its predecessor in some respects, it still has problems with limited oral bioavailability.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).